PHASE 16 · COMPETITIVE LANDSCAPE MAP · 23 · ALL-SKU SYNTHESIS
After artefacts 21 + 22 reordered the roadmap, the chain needs the updated competitive map — top 4-5 brands per SKU category with their winning hooks, hero ingredients, pricing, and trust-signal stacks. Synthesized from 6 fresh web searches + 5 brand-PDP scrapes (Nutrafol Women Core, Goli Ashwagandha, Bonafide, RepHresh Pro-B, Uqora) layered on existing pattern decoder (artefact 11 · 8 templates). Outcome: for each SKU we know who to clone, which patterns to steal, where to differentiate. This is the steal-map.
Each category is dominated by 1-2 entrenched players who own retail shelves + clinical-claim defensibility. Our clone-and-capture lane: price 30-50% below premium tier, particle-loaded advertorial above 1500-word ad library, halal+vegan + Asian-validation differentiators, GLP-1-era hook framings the legacy brands miss. The category-leaders below are who we clone for ad mechanics. The pricing ladder below is where we slot in.
#1 dermatologist-recommended hair growth supplement brand (IQVIA survey). Synergen Complex® patent blend: Sensoril Ashwagandha + Tocotrienol + Marine Collagen Peptides + Saw Palmetto + Curcumin. NSF Certified for Sport®. 6-month clinical study claim. Women's Balance 45+ specifically targets perimeno/post-meno hair loss.
Combines telehealth Rx access (minoxidil + spironolactone) with supplements. Wins on Rx-credibility + 24/7 access. NCOA's #1 menopausal hair-loss treatment pick. Subscription model with auto-refill.
GRO serum + supplement combo. Karmatin (vegan keratin) + mung bean extract + red clover. Influencer-led (DTC + Sephora). Plant-based positioning targets clean-beauty cohort + DHT-sensitive hairlines specifically.
Pre-Nutrafol era player. Marine extract (AminoMar®) hero. Strong clinical study library but losing share to DTC newcomers. Now in CVS/Walgreens — pivot from premium to mass.
OUR STEAL · REVIVE POSITIONING
Clone: Nutrafol's clinical-language framing (Synergen Complex narrative → our Lustriva® narrative). Vegamour's vegan/halal cert positioning. Hers' subscribe-and-save model.
Differentiate: $54 vs Nutrafol's $88 (-39%). GLP-1 hair-loss specific angle (Mounjaro/Ozempic users) — Nutrafol doesn't own this wedge yet. Halal cert + vegan pectin base (Aisha cohort unlock).
Templates cloned (artefact 11): T1 Reluctant Nurse + T7 Nutrafol Replacement + T5 Drum-Tight Belly (UGC).
KSM-66® Ashwagandha 150mg + Vitamin D. B-Corp certified. Subscribe & save $14.88. "Relax. Restore. Unwind." 3-pillar framing. Volume-distribution: Amazon + Target + Walgreens + DTC. Donates 6-month child vitamin supply per order — values-driven hook.
Olly launched Hello Happy — saffron + Vit D gummy. Sold out first run within a week — proves cold demand for saffron-as-stress-hero. Subscription via Target + Walgreens partnerships. Brand voice: cheerful, mass-market, gen-Z lean.
Top-5 ashwagandha brand. $17.99 subscribe + 10% off + free shipping. Pharmacist-recommended legacy positioning. Less DTC presence, more retail-shelf dominance.
Saffron + GABA + lemon balm + ashwagandha multi-stack. Doctor-formulated framing. Costco + Sam's Club volume play. Targets older-millennial mom-cohort.
OUR STEAL · CALM POSITIONING
Clone: Olly's saffron-hero framing (Hello Happy proved the market). Goli's KSM-66 standardization claim. Nature's Bounty's multi-stack credibility.
Differentiate: $34 sits between Goli ($14) and Bonafide-style premium ($35+). Linda-cohort PubMed citation (PMID 30178412 saffron + 31728244 ashwagandha) baked into PDP. Particle-loaded advertorial that the gen-Z-leaning Goli/Olly miss.
Templates cloned: T2 Mom-Burnout Chemistry + T8 What-They're-Hiding.
40+ clinical studies. 1,465,000+ women served. 13,000+ doctors recommend. Dr Alyssa Dweck MS MD FACOG (CMO). Hormone-free positioning across product line. Featured in Good Morning America, NYT, Memorial Sloan Kettering, Allure. Symptom-stack approach: Noctera (sleep) + Revaree (vaginal dryness) + Thermella (hot flashes) + Relizen (overall meno).
P&G-backed one-stop-shop. Supplements + telehealth access + curated education. Multi-product retailer carrying Bonafide-tier and own-brand. Younger DTC voice. Trust signal: P&G corporate backing.
#1 pharmacist-recommended brand. Patented Cissus quadrangularis CQR-300® for hot flashes + anxiety. No synthetic/animal hormones. Mass-retail (CVS/Walgreens) + Amazon. Legacy mainstream player.
Me.No.Pause main SKU + adjacent body-care line (body lotion, neck cream, vaginal moisturizer). Lifestyle aesthetic — Goop-adjacent. Available at Target. Younger-meno cohort (40-50). Co-founded by Sally Mueller (ex-Marks & Spencer).
OLLY's menopause-stack extension. Leverages existing trust + retail distribution from supplement-aisle dominance. Wins on retail-presence + price. Loses on clinical-credibility.
OUR STEAL · PIVOT POSITIONING
Clone: Bonafide's clinical-study citation density (40+ studies framing). Versalie's "demystify menopause" tone. Estroven's "without hormones" claim.
Differentiate: $44 sits between Estroven ($28) and Bonafide ($75). OB/GYN cosign secured before fire (Doctrine 7). Particle-loaded 1500-word advertorials beat all 5 leaders' 200-word PDPs. Halal cert + clinical-grade positioning for global cohort.
Templates cloned: T2 Mom-Burnout Chemistry + T4 It's-Not-Arthritis + T8 What-They're-Hiding.
#1 trusted brand recommended by gynecologists. 5B CFU per serving. Clinically tested L. rhamnosus GR-1® + L. reuteri RC-14®. "Specially formulated by doctors at the Canadian Research and Development Centre for Probiotics." Clinical claim: works within 7 days. Single capsule daily.
Pharmacist-recommended. Daily probiotic + supporting vaginal pH balance. Mass-retail (CVS/Walgreens/Target). Strong Amazon presence — best-seller in probiotic category. Bundle with AZO Cranberry (UTI prevention) = BLOOM+SHIELD adjacency.
10B CFU (2× RepHresh). L. acidophilus + L. rhamnosus + L. reuteri + cranberry extract combo. Wins on DTC voice + lifestyle branding (HUM = Sephora-adjacent). Younger cohort. Cross-sells with HUM's broader supplement line.
Dr-formulated (Dr Aalia Al-Barwani). D-mannose + cranberry + probiotic stack. Both capsule + powder stick-pack formats. Strong UGC strategy on TikTok. Cross-category: covers BOTH BLOOM (probiotic) + SHIELD (UTI prevention) — one of the few players doing this.
OUR STEAL · BLOOM POSITIONING
Clone: RepHresh's 7-day clinical claim + named strain transparency. HUM's DTC lifestyle voice. AZO's mass-retail trust pack.
Differentiate: $59 premium tier — Patricia Wong cohort tolerates premium IF FDA-registered facility named (artefact 15). Dr Haver-style OB/GYN cosign. 10B CFU multi-strain (matches HUM, beats RepHresh's 5B). Cross-bundle with SHIELD at $89.
Templates cloned: T6 Daily Gummy No-Dryness + T7 Nutrafol Replacement (positioning vs RepHresh).
Strongest direct-response play in berberine category. "Strongest berberine supplement for weight loss" framing. Mass advertorial-style ad strategy on Meta. Founder-led brand-voice. Aggressive subscription discounting.
Athlete-credibility premium tier (Andrew Huberman partnership). Berberine HCl + dihydroberberine combos. NSF Certified for Sport. Mid-aspirational audience (45-55 high-income).
Founded by nutritionist Jessica Sepel. Australian DTC origin — global expansion. Women-forward voice. Metabolism + Skin Hair Nails bestsellers. Mid-tier price + IG-influencer-heavy distribution.
Akkermansia muciniphila probiotic — gut-mechanism-led metabolic claim. PhD-founded. Halle Berry investor. Most clinically advanced framing. Higher price = trust signal.
Amazon-volume play. Berberine + chromium + inositol + ACV stack. Mass-Amazon strategy + value-pricing. Wins on shelf-discovery, not on differentiation.
OUR STEAL · SHIFT POSITIONING
Clone: NativePath's "natural Ozempic alternative" framing (HIGH risk — must skirt Meta auto-classifier). JSHealth's women-forward voice + 250K+ social proof. Pendulum's mechanism-led narrative.
Differentiate: $44 hits JSHealth's tier — undercuts NativePath ($59) and Momentous ($65). Doctrine 9 gate: Meta ad-policy advisory consult + clinical-claim legal review BEFORE any spend. Frame as "menopause body shift support / metabolic resilience" — never "weight loss." GLP-1-cohort wedge via REVIVE cross-bundle ($79 REVIVE+SHIFT combo).
Templates cloned: T1 Reluctant Nurse + T7 Nutrafol Replacement (positioning) + NEW T9 GLP-1-Substitute hook archetype.
America's #1 urinary tract drink mix (Circana data). 800,000+ customers served. Available CVS/Target/Walgreens/Walmart. Board-certified doctors on advisory team. Product line: Flush Advanced+ · In Control · Defend. 60-day money-back. 4.0-4.8★ across products. Strong "proactive vs reactive" positioning.
25% market share in cranberry-supplement category. Pharmacist-recommended. Mass-retail anchor. Cranberry softgels + gummies + drink mixes. Cross-bundles with AZO Complete Feminine Balance (BLOOM-adjacent).
21% market share in cranberry category. Clinically-studied dose of cranberry PACs (36mg standardized). Doctor-distributed (urologist offices). Most clinically rigorous brand. Higher price = trust.
Only cranberry + D-mannose supplement independently NSF-certified. Theralogix is a clinically-focused brand (also makes fertility supplements). Doctor-distributed and consumer-direct. Trust-signal hero positioning.
(Repeat from BLOOM rank 4.) Dr-formulated D-mannose + cranberry. Covers BLOOM + SHIELD with one brand. Capsule + powder stick. TikTok-strong. Cross-category play we should clone — single brand sells both probiotic + UTI prevention.
OUR STEAL · SHIELD POSITIONING
Clone: Uqora's "proactive vs reactive" positioning (the entire DTC playbook). AZO's mass-retail trust pack. Ellura's 36mg PACs standardized claim. TheraCran's NSF cert positioning. Happy V's dual-category bundling.
Differentiate: $39 matches Uqora exactly — competes head-on. Post-meno cohort lean (50+ where Uqora skews younger). BLOOM+SHIELD bundle at $89 (-$9) for Patricia/Mei cohort — Uqora doesn't have a vaginal-probiotic sibling. Estrogen-decline narrative (artefact 22 finding) Uqora doesn't own.
Templates cloned: T1 Reluctant Nurse (low-shame voice) + T4 It's-Not-Arthritis (estrogen-decline reveal).
| Category | Value tier | Mid tier | OUR PRICE | Premium tier | Lux tier |
|---|---|---|---|---|---|
| REVIVE Hair | Viviscal $40 | Vegamour $58 | $54 | Nutrafol $88 | Hers Rx $65+ |
| CALM Saffron | Goli $14 | Nature Made $18 | $34 | Bonafide-tier $35-45 | — |
| PIVOT Meno | OLLY $18 | Estroven $28 · Womaness $38 | $44 | Bonafide $60-80 | Versalie premium $90 |
| BLOOM Vaginal | AZO $24 | RepHresh $28 · HUM $26 | — | $59 | Happy V Pro $45+ |
| SHIFT Metabolic | Codeage $32 | JSHealth $44 ← match | $44 | NativePath $59 · Momentous $65 | Pendulum $65 |
| SHIELD Bladder | AZO $18 | Happy V $32 | $39 | Uqora $39 (HEAD-ON) | Ellura $45 · TheraCran $42 |
Pattern: we sit in the mid-to-premium band for all 6 SKUs except BLOOM (we go full premium @ $59 due to Patricia trust requirements). Average price point $46 — clears 80%+ gross margins at $6-7 landed COGS, premium enough to support advertorial spend.
| Category | MUST-HAVE | NICE-TO-HAVE | WINNER-SIGNAL |
|---|---|---|---|
| REVIVE | NSF cert + 3rd-party COA + dermatologist mention | Halal cert + IFANCA + Trustpilot 100+ | Named clinical study (Nutrafol-style 6-mo trial) |
| CALM | KSM-66 brand-name (or Affron® saffron) + Vit D combo + B-Corp or similar values stamp | Reddit testimonials | PMID citations in PDP (Linda cohort) |
| PIVOT | OB/GYN cosign · Doctrine 7 gate · hormone-free claim · clinical-study count | NYT/Allure mentions | Dr Mary Claire Haver-style named physician on advisory board |
| BLOOM | Named strains (L. crispatus + GR-1 + RC-14) · FDA-registered facility · 500+ Trustpilot | Halal + vegan | OB/GYN advisory board + 10B+ CFU vs RepHresh's 5B |
| SHIFT | Meta ad-policy clearance (Doctrine 9) · NSF · "no Rx" / "no GLP-1" disclaimer · PMID 33704780 | Influencer testimonial | Avoid "weight loss" language — frame as "metabolic resilience" / "body shift" |
| SHIELD | D-Mannose 1g + Cranberry PACs 36mg standardized + 60-day money-back | NSF cert (matches TheraCran) | Urologist advisory board + lab-verified PAC dose |
| Month | SKU | Clone leader(s) | Price · target margin |
|---|---|---|---|
| M1 | REVIVE Hair | Nutrafol + Vegamour | $54 · 87% margin |
| M1-2 | CALM Saffron (attach) | Olly + Goli | $34 · 80% margin |
| M3 | PIVOT MenoBalance · Doctrine 7 OB/GYN gate | Bonafide + Versalie | $44 · 82% margin |
| M4 | BLOOM Vaginal · 500-review gate | RepHresh + HUM | $59 · 85% margin |
| M5 | SHIFT Metabolic ← NEW from 22 · Doctrine 9 ad-policy gate | NativePath + JSHealth + Pendulum | $44 · 85% margin |
| M6 | SHIELD Bladder ← NEW from 22 | Uqora + AZO + Ellura | $39 · 78% margin |
| M8 | FORTIFY Bone+Joint (after bundle test) | Theralogix · open-niche · low entrenched | $44 · 85% margin |
| M9+ | Bust gummy (Felicia · diaspora) · K-variant ($69 KIST) · DACH/EFSA | WHITESPACE bust gummy + AZO+Pendulum K-mirror + Reformhaus partner | various |
| Update | Target | Owner |
|---|---|---|
| "Natural Ozempic alternative" hook added to T9 template archetype (was 8 templates, now 9). | artefact 11 pattern decoder | creative-director |
| Cross-SKU bundle pricing formalized: REVIVE+CALM $79, REVIVE+SHIFT $79, BLOOM+SHIELD $89, meno-trio (PIVOT+BLOOM+CALM) $129. Add to PDP cross-sell logic. | artefact 16 launch kit Phase 2 | marketing |
| Doctrine 9 ad-policy gate formalized: SHIFT requires Meta ad-policy advisory consult + clinical-claim legal review before any spend. Same gate-discipline as PIVOT Doctrine 7. | artefact 09 doctrines | Jenn approval |
| 10B CFU upgrade for BLOOM (currently spec at 5B in earlier artefacts) to beat RepHresh + match HUM. Adds ~$0.40 to landed COGS but moves us out of "me-too" tier. | artefact 18 execution kit (BLOOM-specific) · earlier was for REVIVE only | marketing |
| Happy V cross-category playbook noted — single brand selling BOTH BLOOM (probiotic) + SHIELD (UTI) — our BLOOM+SHIELD bundle replicates this cross-category retention. Add to artefact 16 line-architecture. | artefact 16 line architecture | Jenn + marketing |
ARTEFACT 23 · COMPETITIVE LANDSCAPE MAPPED · STEAL-MAP COMPLETE
The chain now has full clone-and-capture coverage for all 6 SKUs — REVIVE (Nutrafol target) · CALM (Olly/Goli target) · PIVOT (Bonafide target · Doctrine 7 gated) · BLOOM (RepHresh target · 500-review gated) · SHIFT (NativePath/JSHealth target · Doctrine 9 gated) · SHIELD (Uqora target · head-on $39 match). Average price point $46 · average margin 83% · cross-SKU bundles unlock 1.4× AOV. The map is shippable. Next: actually mint the SHIFT + SHIELD ad_ids and start the Day -14 schedule when Jenn greenlights.